Níveis séricos de proteína de células de Clara de 16kDa e comprometimento pulmonar em pacientes com esclerose sistêmica

Clinical significance of serum levels of secretory leukocyte protease inhibitor in patients with systemic sclerosis

(2014) Naohiko Aozasa et al.   Modern Rheumatology

Serum Adhesion Molecule Levels as Prognostic Markers in Patients with Early Systemic Sclerosis: A Multicentre, Prospective, Observational Study

(2014) Minoru Hasegawa et al.   PLoS One

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

Use of Serum Clara Cell 16-kDa (CC16) Levels as a Potential Indicator of Active Pulmonary Fibrosis in Systemic Sclerosis

(2011) MINORU HASEGAWA et al.   JOURNAL OF RHEUMATOLOGY

Scleroderma Lung Disease

(2010) Jérôme Le Pavec et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Interstitial Lung Disease in Systemic Sclerosis

(2008) Nicole S. L. Goh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE